An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209657
Company: CIPLA

Products on ANDA 209657

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
PACLITAXEL	PACLITAXEL	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 209657

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/10/2025	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 209657

PACLITAXEL

POWDER;INTRAVENOUS; 100MG/VIAL
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ABRAXANE	PACLITAXEL	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AB	021660	BRISTOL-MYERS
PACLITAXEL	PACLITAXEL	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AB	211875	AM REGENT
PACLITAXEL	PACLITAXEL	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AB	209657	CIPLA
PACLITAXEL	PACLITAXEL	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AB	212700	HENGRUI PHARMA
PACLITAXEL	PACLITAXEL	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AB	217877	MYLAN
PACLITAXEL	PACLITAXEL	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AB	216355	SHUANGCHENG
PACLITAXEL	PACLITAXEL	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AB	216338	TEVA PHARMS INC

Top